Pancreatic Cancer Research

ResearcherTUM KlinikumActive in the last 2 years

Zahra Dantes

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4625-2524; OpenAlex author ID A5080379706. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
82
Papers, trials and grants by year

2018: 3 papers · 2019: none · 2020: 3 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 9

  1. Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. Co-author DOI 10.1016/j.xcrm.2024.101927↗
  2. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology. Co-author DOI 10.1053/j.gastro.2020.09.010↗
  3. Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance. Co-author DOI 10.1158/1535-7163.mct-20-0981↗
  4. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype. Co-author DOI 10.1136/gutjnl-2018-317856↗
  5. Loss of Wasl improves pancreatic cancer outcome. Co-author DOI 10.1172/jci.insight.127275↗
  6. Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. Co-author DOI 10.1172/jci.insight.137809↗
  7. β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2017.11.007↗
  8. Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer. Co-author DOI 10.1016/j.jcmgh.2017.12.004↗
  9. MTOR inhibitor-based combination therapies for pancreatic cancer. Co-author DOI 10.1038/bjc.2017.421↗

Closest collaborators

The 25 strongest of 82 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maximilian Reichert · 9 shared papers, 2018–2025 · strength 0.83
  2. Roland Rad · 5 shared papers, 2018–2021 · strength 0.40
  3. Roland Michael Schmid · 4 shared papers, 2018–2021 · strength 0.32
  4. Wilko Weichert · 4 shared papers, 2018–2021 · strength 0.31
  5. Günter Schneider · 4 shared papers, 2018–2021 · strength 0.31
  6. Dieter Saur · 4 shared papers, 2018–2021 · strength 0.31
  7. Helmut Frieß · 2 shared papers, 2020–2025 · strength 0.24
  8. Matthias Wirth · 3 shared papers, 2018–2020 · strength 0.21
  9. Xiaoping Zou · 1 shared paper, 2025 · strength 0.18
  10. Chao Fang · 1 shared paper, 2025 · strength 0.18
  11. Zipeng Lu · 1 shared paper, 2025 · strength 0.18
  12. Yifeng Sun · 1 shared paper, 2025 · strength 0.18
  13. Yoshiaki Sunami · 1 shared paper, 2025 · strength 0.18
  14. Susanne Roth · 1 shared paper, 2025 · strength 0.18
  15. Hongzhen Li · 1 shared paper, 2025 · strength 0.18
  16. Martin Loos · 1 shared paper, 2025 · strength 0.18
  17. Zhiheng Zhang · 1 shared paper, 2025 · strength 0.18
  18. Shanshan Shen · 1 shared paper, 2025 · strength 0.18
  19. Shuang Nie · 1 shared paper, 2025 · strength 0.18
  20. Christoph W. Michalski · 1 shared paper, 2025 · strength 0.18
  21. Jorg H. Kleeff · 1 shared paper, 2025 · strength 0.18
  22. Kuirong Jiang · 1 shared paper, 2025 · strength 0.18
  23. Christoph Kahlert · 1 shared paper, 2025 · strength 0.18
  24. Ingrid Herr · 1 shared paper, 2025 · strength 0.18
  25. Katja Peschke · 2 shared papers, 2020–2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.